Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famitinib in Recurrent/Metastatic Nasopharyngeal Carcinoma
NCT01392235Phase 2Completed
- Sponsor
- Hengrui
- Start
- Jul 2011
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of famitinib in nasopharyngeal carcinoma (NPC), sponsored by Hengrui. Started Jul 2011; status: completed.
02
Drugs
famitinib
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT01392235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01392235.